SCHWARTZ MARK W. 4/A
4/A · Galena Biopharma, Inc. · Filed Jan 31, 2013
Insider Transaction Report
Form 4/AAmended
SCHWARTZ MARK W.
EVP Chief Operating Officer
Transactions
- Award
Common Stock
2011-04-13+330,872→ 330,872 total
Footnotes (1)
- [F1]The shares shown were received by Reporting Person in exchange for 2,776,796 shares of Apthera, Inc. ("Apthera") common stock in connection with the Issuer's merger acquisition of Apthera, with Apthera surviving as a wholly-owned subsidiary of the Issuer (the "Merger"). On the effective date of the Merger, the closing price of the Issuer's common stock was $1.275 per share. The shares shown exclude 6,789 shares, which were included in error in the Reporting Person's original Form 4.